The novel treatment of the medication represents a major breakthrough in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 https://tirzepatide-peptide584941.bloginwi.com/75939331/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment